Efficacy Safety and Tolerability of Multiple Doses of Oshadi Icp (Oshadi Oral Insulin) in Patients With Type 1 Diabetes Mellitus - Phase II Clinical Study

NCT01973920 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus
Insulin-Dependent
Type 1

Interventions

DRUG: Oshadi Icp

Sponsor

Oshadi Drug Administration